Cargando…

Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients

C1-inhibitor (C1-INH) is an important regulator of the complement, coagulation, fibrinolytic and contact systems. The quantity of protease/C1-INH complexes in the blood is proportional to the level of the in vivo activation of these four cascade-like plasma enzyme systems. Parallel determination of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kajdácsi, Erika, Jandrasics, Zsófia, Veszeli, Nóra, Makó, Veronika, Koncz, Anna, Gulyás, Dominik, Köhalmi, Kinga Viktória, Temesszentandrási, György, Cervenak, László, Gál, Péter, Dobó, József, de Maat, Steven, Maas, Coen, Farkas, Henriette, Varga, Lilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214733/
https://www.ncbi.nlm.nih.gov/pubmed/32431708
http://dx.doi.org/10.3389/fimmu.2020.00794
_version_ 1783532031478595584
author Kajdácsi, Erika
Jandrasics, Zsófia
Veszeli, Nóra
Makó, Veronika
Koncz, Anna
Gulyás, Dominik
Köhalmi, Kinga Viktória
Temesszentandrási, György
Cervenak, László
Gál, Péter
Dobó, József
de Maat, Steven
Maas, Coen
Farkas, Henriette
Varga, Lilian
author_facet Kajdácsi, Erika
Jandrasics, Zsófia
Veszeli, Nóra
Makó, Veronika
Koncz, Anna
Gulyás, Dominik
Köhalmi, Kinga Viktória
Temesszentandrási, György
Cervenak, László
Gál, Péter
Dobó, József
de Maat, Steven
Maas, Coen
Farkas, Henriette
Varga, Lilian
author_sort Kajdácsi, Erika
collection PubMed
description C1-inhibitor (C1-INH) is an important regulator of the complement, coagulation, fibrinolytic and contact systems. The quantity of protease/C1-INH complexes in the blood is proportional to the level of the in vivo activation of these four cascade-like plasma enzyme systems. Parallel determination of C1-INH-containing activation complexes could be important to understand the regulatory role of C1-INH in diseases such as hereditary angioedema (HAE) due to C1-INH deficiency (C1-INH-HAE). We developed in-house ELISAs to measure the concentration of complexes of C1-INH formed with active proteases: C1r, C1s, MASP-1, MASP-2, plasma kallikrein, factor XIIa, factor XIa, and thrombin, as well as to determine total and functionally active C1-INH. We measured the concentration of the complexes in EDTA plasma from 6 healthy controls, from 5 with type I and 5 with type II C1-INH-HAE patients during symptom-free periods and from five patients during HAE attacks. We also assessed the concentration of these complexes in blood samples taken from one C1-INH-HAE patient during the kinetic follow-up of a HAE attack. The overall pattern of complexed C1-INH was similar in controls and C1-INH-HAE patients. C1-INH formed the highest concentration complexes with C1r and C1s. We observed higher plasma kallikrein/C1-INH complex concentration in both type I and type II C1-INH-HAE, and higher concentration of MASP-1/C1-INH, and MASP-2/C1-INH complexes in type II C1-INH-HAE patients compared to healthy controls and type I patients. Interestingly, none of the C1-INH complex concentrations changed significantly during HAE attacks. During the kinetic follow-up of an HAE attack, the concentration of plasma kallikrein/C1-INH complex was elevated at the onset of the attack. In parallel, C1r, FXIIa and FXIa complexes of C1-INH also tended to be elevated, and the changes in the concentrations of the complexes followed rather rapid kinetics. Our results suggest that the complement classical pathway plays a critical role in the metabolism of C1-INH, however, in C1-INH-HAE, contact system activation is the most significant in this respect. Due to the fast changes in the concentration of complexes, high resolution kinetic follow-up studies are needed to clarify the precise molecular background of C1-INH-HAE pathogenesis.
format Online
Article
Text
id pubmed-7214733
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72147332020-05-19 Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients Kajdácsi, Erika Jandrasics, Zsófia Veszeli, Nóra Makó, Veronika Koncz, Anna Gulyás, Dominik Köhalmi, Kinga Viktória Temesszentandrási, György Cervenak, László Gál, Péter Dobó, József de Maat, Steven Maas, Coen Farkas, Henriette Varga, Lilian Front Immunol Immunology C1-inhibitor (C1-INH) is an important regulator of the complement, coagulation, fibrinolytic and contact systems. The quantity of protease/C1-INH complexes in the blood is proportional to the level of the in vivo activation of these four cascade-like plasma enzyme systems. Parallel determination of C1-INH-containing activation complexes could be important to understand the regulatory role of C1-INH in diseases such as hereditary angioedema (HAE) due to C1-INH deficiency (C1-INH-HAE). We developed in-house ELISAs to measure the concentration of complexes of C1-INH formed with active proteases: C1r, C1s, MASP-1, MASP-2, plasma kallikrein, factor XIIa, factor XIa, and thrombin, as well as to determine total and functionally active C1-INH. We measured the concentration of the complexes in EDTA plasma from 6 healthy controls, from 5 with type I and 5 with type II C1-INH-HAE patients during symptom-free periods and from five patients during HAE attacks. We also assessed the concentration of these complexes in blood samples taken from one C1-INH-HAE patient during the kinetic follow-up of a HAE attack. The overall pattern of complexed C1-INH was similar in controls and C1-INH-HAE patients. C1-INH formed the highest concentration complexes with C1r and C1s. We observed higher plasma kallikrein/C1-INH complex concentration in both type I and type II C1-INH-HAE, and higher concentration of MASP-1/C1-INH, and MASP-2/C1-INH complexes in type II C1-INH-HAE patients compared to healthy controls and type I patients. Interestingly, none of the C1-INH complex concentrations changed significantly during HAE attacks. During the kinetic follow-up of an HAE attack, the concentration of plasma kallikrein/C1-INH complex was elevated at the onset of the attack. In parallel, C1r, FXIIa and FXIa complexes of C1-INH also tended to be elevated, and the changes in the concentrations of the complexes followed rather rapid kinetics. Our results suggest that the complement classical pathway plays a critical role in the metabolism of C1-INH, however, in C1-INH-HAE, contact system activation is the most significant in this respect. Due to the fast changes in the concentration of complexes, high resolution kinetic follow-up studies are needed to clarify the precise molecular background of C1-INH-HAE pathogenesis. Frontiers Media S.A. 2020-05-05 /pmc/articles/PMC7214733/ /pubmed/32431708 http://dx.doi.org/10.3389/fimmu.2020.00794 Text en Copyright © 2020 Kajdácsi, Jandrasics, Veszeli, Makó, Koncz, Gulyás, Köhalmi, Temesszentandrási, Cervenak, Gál, Dobó, de Maat, Maas, Farkas and Varga. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Kajdácsi, Erika
Jandrasics, Zsófia
Veszeli, Nóra
Makó, Veronika
Koncz, Anna
Gulyás, Dominik
Köhalmi, Kinga Viktória
Temesszentandrási, György
Cervenak, László
Gál, Péter
Dobó, József
de Maat, Steven
Maas, Coen
Farkas, Henriette
Varga, Lilian
Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients
title Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients
title_full Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients
title_fullStr Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients
title_full_unstemmed Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients
title_short Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients
title_sort patterns of c1-inhibitor/plasma serine protease complexes in healthy humans and in hereditary angioedema patients
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214733/
https://www.ncbi.nlm.nih.gov/pubmed/32431708
http://dx.doi.org/10.3389/fimmu.2020.00794
work_keys_str_mv AT kajdacsierika patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT jandrasicszsofia patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT veszelinora patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT makoveronika patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT konczanna patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT gulyasdominik patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT kohalmikingaviktoria patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT temesszentandrasigyorgy patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT cervenaklaszlo patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT galpeter patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT dobojozsef patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT demaatsteven patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT maascoen patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT farkashenriette patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients
AT vargalilian patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients